New hope for head and neck cancer patients who stopped responding to immunotherapy

NCT ID NCT05283226

First seen Jan 25, 2026 · Last updated May 16, 2026 · Updated 12 times

Summary

This study tests a new oral drug (NRC-2694-A) taken with chemotherapy (paclitaxel) in people with advanced head and neck cancer that has returned or spread and no longer responds to immunotherapy. About 21 adults will participate to see if the combination shrinks tumors. The goal is to find a better treatment option for this hard-to-treat cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Basavatarakam Indo American Cancer Hospital & Research Institute

    NOT_YET_RECRUITING

    Hyderabad, Telangana, 500034, India

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Dartmouth Hitchcock Medical Center

    COMPLETED

    Lebanon, New Hampshire, 03756-1000, United States

  • Daycare Angels under AOH

    RECRUITING

    Mumbai, Maharashtra, 40001, India

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Grant Medical Foundation Ruby Hall Clinic

    COMPLETED

    Pune, Maharashtra, 411001, India

  • Los Angeles Hematology Oncology Medical Group

    COMPLETED

    Los Angeles, California, 90017, United States

  • Lynn Cancer Center

    COMPLETED

    Boca Raton, Florida, 33486, United States

  • Miami Cancer Center

    COMPLETED

    Miami, Florida, 33176, United States

  • Norton Cancer Institute - Downtown

    COMPLETED

    Louisville, Kentucky, 40202, United States

  • Providence Medical Foundation -Fullerton

    COMPLETED

    Fullerton, California, 92835, United States

  • Salib Oncology

    COMPLETED

    Easton, Pennsylvania, 18045, United States

  • University of Maryland Greenebaum Cancer Center

    COMPLETED

    Baltimore, Maryland, 21201-1544, United States

  • University of Wisconsin Carbone Cancer Center

    COMPLETED

    Madison, Wisconsin, 53792, United States

  • Washington University - Siteman Cancer Center

    COMPLETED

    St Louis, Missouri, 63110, United States

Conditions

Explore the condition pages connected to this study.